Targeting cellular energy metabolism- mediated ferroptosis by small molecule compounds for colorectal cancer therapy

References

• Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4(11):891–899.
   PubMed Web of Science ®Google Scholar
• Metallo CM, Vander Heiden MG. Metabolism strikes back: metabolic flux regulates cell signaling. Genes Dev. 2010;24(24):2717–2722.
   PubMedGoogle Scholar
• Locasale JW, Cantley LC. Metabolic flux and the regulation of mammalian cell growth. Cell Metab. 2011;14(4):443–451.
   PubMed Web of Science ®Google Scholar
• La Vecchia S, Sebastián C. Metabolic pathways regulating colorectal cancer initiation and progression. Semin Cell Dev Biol. 2020;98:63–70.
   PubMed Web of Science ®Google Scholar
• Pan T, Liu J, Xu S, et al. ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells. Theranostics. 2020;10(2):516–536.
   PubMed Web of Science ®Google Scholar
• Munir R, Lisec J, Jaeger C, et al. Abundance, fatty acid composition and saturation index of neutral lipids in colorectal cancer cell lines. Acta Biochim Pol. 2021;68(1):115–118.
   PubMedGoogle Scholar
• Circu ML, Maloney RE, Aw TY. Diquat-induced cellular pyridine nucleotide redox changes and alteration of metabolic enzyme activities in colonic carcinoma cells. Chem Biol Interact. 2017;264:43–51.
   PubMedGoogle Scholar
• Gong J, Lin Y, Zhang H, et al. Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells. Cell Death Dis. 2020;11(4):267.
   PubMedGoogle Scholar
• Lin R, Tao R, Gao X, et al. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol Cell. 2013;51(4):506–518.
   PubMed Web of Science ®Google Scholar
• Harjes U, Kalucka J, Carmeliet P. Targeting fatty acid metabolism in cancer and endothelial cells. Crit Rev Oncol Hematol. 2016;97:15–21.
   PubMed Web of Science ®Google Scholar
• Peng S, Chen D, Cai J, et al. Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives Colon cancer peritoneal metastasis. Mol Oncol. 2021;15(5):1391–1411.
   PubMedGoogle Scholar
• Wang YN, Zeng ZL, Lu J, et al. CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis. Oncogene. 2018;37(46):6025–6040.
   PubMed Web of Science ®Google Scholar
• Wang G, Wang YZ, Yu Y, et al. Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis Mill. J Ethnopharmacol. 2019;235:255–267.
   PubMed Web of Science ®Google Scholar
• Graboń W, Otto-Ślusarczyk D, Chrzanowska A, et al. Lactate formation in primary and metastatic Colon cancer cells at hypoxia and normoxia. Cell Biochem Funct. 2016;34(7):483–490.
   PubMedGoogle Scholar
• Navrátilová J, Hankeová T, Beneš P, et al. Acidic pH of tumor microenvironment enhances cytotoxicity of the disulfiram/Cu2+ complex to breast and Colon cancer cells. Chemotherapy. 2013;59(2):112–120.
   PubMedGoogle Scholar
• Bebber CM, Müller F, Prieto Clemente L, et al. Ferroptosis in cancer cell biology. Cancers (Basel). 2020;12(1):164.
   PubMedGoogle Scholar
• Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405–414.
   PubMed Web of Science ®Google Scholar
• Demuynck R, Efimova I, Naessens F, et al. Immunogenic ferroptosis and where to find it? J Immunother Cancer. 2021;9(12):e003430.
   PubMedGoogle Scholar
• Song IS, Jeong YJ, Jeong SH, et al. FOXM1-induced PRX3 regulates stemness and survival of colon cancer cells via maintenance of mitochondrial function. Gastroenterology. 2015;149(4):1006–1016.e9.
   PubMed Web of Science ®Google Scholar
• Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer. 2009;100(9):1369–1372.
   PubMed Web of Science ®Google Scholar
• Casanova MR, Azevedo-Silva J, Rodrigues LR, et al. Colorectal cancer cells increase the production of short chain fatty acids by Propionibacterium freudenreichii impacting on. Front Nutr. 2018;5:44.
   PubMedGoogle Scholar
• Karshovska E, Wei Y, Subramanian P, et al. HIF-1α (hypoxia-inducible factor-1α) promotes macrophage necroptosis by regulating miR-210 and miR-383. Arterioscler Thromb Vasc Biol. 2020;40(3):583–596.
   PubMedGoogle Scholar
• Hashmi S, Yi W, Suman DS, et al. Human cancer: is it linked to dysfunctional lipid metabolism? Biochim Biophys Acta. 2015;1850(2):352–364.
   PubMedGoogle Scholar
• Huang C, Freter C. Lipid metabolism, apoptosis and cancer therapy. Int J Mol Sci. 2015;16(1):924–949.
   PubMed Web of Science ®Google Scholar
• Raulien N, Friedrich K, Strobel S, et al. Fatty acid oxidation compensates for lipopolysaccharide-induced Warburg effect in glucose-deprived monocytes. Front Immunol. 2017;8:609.
   PubMed Web of Science ®Google Scholar
• Wu X, Qian S, Zhang J, et al. Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer. Cancer Metab. 2021;9(1):23.
   PubMedGoogle Scholar
• Tam JM, Mansour MK, Khan NS, et al. Use of fungal derived polysaccharide-conjugated particles to probe Dectin-1 responses in innate immunity. Integr Biol (Camb). 2012;4(2):220–227.
   PubMedGoogle Scholar
• Ke R, Xu Q, Li C, et al. Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism. Cell Biol Int. 2018;42(4):384–392.
   PubMed Web of Science ®Google Scholar
• Herms A, Bosch M, Reddy BJN, et al. AMPK activation promotes lipid droplet dispersion on detyrosinated microtubules to increase mitochondrial fatty acid oxidation. Nat Commun. 2015;6:7176.
   PubMed Web of Science ®Google Scholar
• Rambold AS, Cohen S, Lippincott-Schwartz J. Fatty acid trafficking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics. Dev Cell. 2015;32(6):678–692.
   PubMed Web of Science ®Google Scholar
• Bartz R, Li WH, Venables B, et al. Lipidomics reveals that adiposomes store ether lipids and mediate phospholipid traffic. J Lipid Res. 2007;48(4):837–847.
   PubMed Web of Science ®Google Scholar
• Huang Y-l, Morales-Rosado J, Ray J, et al. Toll-like receptor agonists promote prolonged triglyceride storage in macrophages. J Biol Chem. 2014;289(5):3001–3012.
   PubMed Web of Science ®Google Scholar
• Bertini I, Cacciatore S, Jensen BV, et al. Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res. 2012;72(1):356–364.
   PubMedGoogle Scholar
• Yang J, Nishihara R, Zhang X, et al. Energy sensing pathways: bridging type 2 diabetes and colorectal cancer? J Diabetes Complications. 2017;31(7):1228–1236.
   PubMed Web of Science ®Google Scholar
• Hujber Z, Petővári G, Szoboszlai N, et al. Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells. J Exp Clin Cancer Res. 2017;36(1):74.
   PubMedGoogle Scholar
• Riffle S, Hegde RS. Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids. J Exp Clin Cancer Res. 2017;36(1):102.
   PubMedGoogle Scholar
• Wang H, Xi Q, Wu G. Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway. Cancer Med. 2016;5(7):1599–1606.
   PubMed Web of Science ®Google Scholar
• Mika A, Kobiela J, Pakiet A, et al. Preferential uptake of polyunsaturated fatty acids by colorectal cancer cells. Sci Rep. 2020;10(1):1954.
   PubMedGoogle Scholar
• Monirujjaman M, Pant A, Nelson R, et al. Alterations in hepatic fatty acids reveal depletion of total polyunsaturated fatty acids following irinotecan plus 5-fluorouracil treatment in an animal model of colorectal cancer. Prostaglandins Leukot Essent Fatty Acids. 2021;174:102359.
   PubMedGoogle Scholar
• Yan G, Li L, Bo Z, et al. Lipidome in colorectal cancer. Oncotarget. 2016;7(22):33429–33439.
   PubMedGoogle Scholar
• Vargas T, Moreno-Rubio J, Herranz J, et al. 3’UTR polymorphism in ACSL1 gene correlates with expression levels and poor clinical outcome in Colon cancer patients. PLoS One. 2016;11(12):e0168423.
   PubMed Web of Science ®Google Scholar
• Sánchez-Martínez R, Cruz-Gil S, García-Álvarez MS, et al. Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive Colon cancer cells. Sci Rep. 2017;7(1):11143.
   PubMedGoogle Scholar
• Cruz-Gil S, Sanchez-Martinez R, dCM G, et al. Targeting the metabolic axis ACSL/SCD in colorectal cancer progression by therapeutic miRNAs: miR-19b-1 role. J Lipid Res. 2018;59(1):14–24.
   PubMedGoogle Scholar
• Bezaire V, Bruce CR, Heigenhauser GJ, et al. Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. Am J Physiol Endocrinol Metabol. 2006;290(3):E509–E515.
   PubMedGoogle Scholar
• Taymaz-Nikerel H, De MM, Baart GJ, et al. Comparative fluxome and metabolome analysis for overproduction of succinate in Escherichia coli. Biotechnol Bioeng. 2016;113(4):817–829.
   PubMedGoogle Scholar
• Wright HJ, Hou J, Xu B, et al. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation. Proc Natl Acad Sci USA. 2017;114(32):E6556–E6565.
   Google Scholar
• Marín-Hernández A, Gallardo-Pérez JC, Rodríguez-Enríquez S, et al. Modeling cancer glycolysis. Biochim Biophys Acta. 2011;1807(6):755–767.
   PubMed Web of Science ®Google Scholar
• Maya S, Sarmento B, Lakshmanan VK, et al. Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing Colon cancer cells. J Biomed Nanotechnol. 2014;10(8):1416–1428.
   PubMed Web of Science ®Google Scholar
• Greening DW, Kapp EA, Ji H, et al. Colon tumour secretopeptidome: Insights into endogenous proteolytic cleavage events in the Colon tumour microenvironment. Biochim Biophys Acta. 2013;1834(11):2396–2407.
   PubMed Web of Science ®Google Scholar
• Yang Z, Hollande F, Baldwin GS. Blockade of long chain fatty acid oxidation by non-steroidal anti-inflammatory drugs may contribute to inhibition of proliferation of human colorectal carcinoma cell lines. Cancer Lett. 1998;124(2):187–191.
   PubMed Web of Science ®Google Scholar
• Al-Khayal K, Alafeefy A, Vaali-Mohammed MA, et al. Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration. BMC Cancer. 2017;17(1):4.
   PubMedGoogle Scholar
• Wong CC, Qian Y, Li X, et al. SLC25A22 promotes proliferation and survival of colorectal cancer cells with KRAS mutations and xenograft tumor progression in mice via intracellular synthesis of aspartate. Gastroenterology. 2016;151(5):945–960.e946.
   PubMedGoogle Scholar
• Rodriguez-Gonzalez JC, Hernández-Balmaseda I, Declerck K, et al. Antiangiogenic, and antimetastatic therapy response by mangiferin in a syngeneic immunocompetent colorectal cancer mouse model involves changes in mitochondrial energy metabolism. Front Pharmacol. 2021;12:670167.
   PubMedGoogle Scholar
• Fauser JK, Matthews GM, Cummins AG, et al. Induction of apoptosis by the Medium-Chain length fatty acid lauric acid in Colon cancer cells due to induction of oxidative stress. Chemotherapy. 2013;59(3):214–224.
   PubMed Web of Science ®Google Scholar
• Kadochi Y, Mori S, Fujiwara-Tani R, et al. Remodeling of energy metabolism by a ketone body and medium-chain fatty acid suppressed the proliferation of CT26 mouse Colon cancer cells. Oncol Lett. 2017;14(1):673–680.
   PubMedGoogle Scholar
• Kim EY, Choi HJ, Park MJ, et al. Myristica fragrans suppresses tumor growth and metabolism by inhibiting lactate dehydrogenase A. Am J Chin Med. 2016;44(5):1063–1079.
   PubMedGoogle Scholar
• Yang Y, Valera VA, Padilla-Nash HM, et al. UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet. 2010;196(1):45–55.
   PubMedGoogle Scholar
• Wu H, Ying M, Hu X. Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation. Oncotarget. 2016;7(26):40621–40629.
   PubMedGoogle Scholar
• Peppicelli S, Toti A, Giannoni E, et al. Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation. Cell Cycle. 2016;15(14):1908–1918.
   PubMed Web of Science ®Google Scholar
• De MP, Delodi G, Vučetić M, et al. Disrupting glucose-6-phosphate isomerase fully suppresses the "Warburg effect" and activates OXPHOS with minimal impact on tumor growth except in hypoxia. Oncotarget. 2017;8(50):87623–87637.
   PubMedGoogle Scholar
• Nie H, Ju H, Fan J, et al. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nat Commun. 2020;11(1):36.
   PubMed Web of Science ®Google Scholar
• Lee H, Zandkarimi F, Zhang Y, et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22(2):225–234.
   PubMed Web of Science ®Google Scholar
• Liu J, Peng Y, Shi L, et al. Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle. Cell Res. 2021;31(1):80–93.
   PubMedGoogle Scholar
• Sonveaux P, Végran F, Schroeder T, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest. 2008;118(12):3930–3942.
   PubMed Web of Science ®Google Scholar
• Gao M, Yi J, Zhu J, et al. Role of mitochondria in ferroptosis. Mol Cell. 2019;73(2):354–363.
   PubMed Web of Science ®Google Scholar
• Shin D, Lee J, You JH, et al. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer. Redox Biol. 2020;30:101418.
   PubMed Web of Science ®Google Scholar
• Zhou B, Liu J, Kang R, et al. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. 2020;66:89–100.
   PubMed Web of Science ®Google Scholar
• DeHart DN, Lemasters JJ, Maldonado EN. Erastin-like anti-Warburg agents prevent mitochondrial depolarization induced by free tubulin and decrease lactate formation in cancer cells. SLAS Discov. 2018;23(1):23–33.
   PubMedGoogle Scholar
• Satoh K, Yachida S, Sugimoto M, et al. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc Natl Acad Sci U S A. 2017;114(37):E7697–E7706.
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85–95.
   PubMed Web of Science ®Google Scholar
• Markert EK, Levine AJ, Vazquez A. Proliferation and tissue remodeling in cancer: the hallmarks revisited. Cell Death Dis. 2012;3:e397.
   PubMed Web of Science ®Google Scholar
• Rabinovitch RC, Samborska B, Faubert B, et al. AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species. Cell Rep. 2017;21(1):1–9.
   PubMed Web of Science ®Google Scholar
• Raina K, Agarwal C, Wadhwa R, et al. Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries. Autophagy. 2013;9(5):697–713.
   PubMed Web of Science ®Google Scholar
• Qiu SL, Xiao ZC, Piao CM, et al. AMP-activated protein kinase α2 protects against liver injury from metastasized tumors via reduced glucose deprivation-induced oxidative stress. J Biol Chem. 2014;289(13):9449–9459.
   PubMed Web of Science ®Google Scholar
• Yu H, Zhang H, Dong M, et al. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells. Int J Oncol. 2017;50(1):161–172.
   PubMedGoogle Scholar
• Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol. 2012;52(1):381–400.
   PubMed Web of Science ®Google Scholar
• Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115(5):577–590.
   PubMed Web of Science ®Google Scholar
• DM G, DB S DE, MM M AM, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Molecular Cell. 2008;30(2):214.
   PubMedGoogle Scholar
• Johnson SM, Gulhati P, Rampy BA, et al. Novel expression patterns of PI3K/akt/mTOR signaling pathway components in colorectal cancer. J Am Coll Surg. 2010;210(5):767–778.
   PubMed Web of Science ®Google Scholar
• Faller WJ, Jackson TJ, Knight JRP, et al. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth. Nature. 2015;517(7535):497–500.
   PubMed Web of Science ®Google Scholar
• Toda K, Kawada K, Iwamoto M, et al. Metabolic alterations caused by KRAS mutations in colorectal cancer contribute to cell adaptation to glutamine depletion by upregulation of asparagine synthetase. Neoplasia. 2016;18(11):654–665.
   PubMed Web of Science ®Google Scholar
• Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10(5):307–318.
   PubMed Web of Science ®Google Scholar
• Csibi A, Lee G, Yoon SO, et al. The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation. Curr Biol. 2014;24(19):2274–2280.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li M, Yao X, et al. HCAR1/MCT1 regulates tumor ferroptosis through the lactate-mediated AMPK-SCD1 activity and its therapeutic implications. Cell Rep. 2020;33(10):108487.
   PubMed Web of Science ®Google Scholar
• Lee H, Zhuang L, Gan B. Energy stress inhibits ferroptosis via AMPK. Mol Cell Oncol. 2020;7(4):1761242.
   PubMed Web of Science ®Google Scholar
• Bates J, Vijayakumar A, Ghoshal S, et al. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. J Hepatol. 2020;73(4):896–905.
   PubMedGoogle Scholar
• Li C, Dong X, Du W, et al. LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis. Signal Transduct Target Ther. 2020;5(1):187.
   PubMed Web of Science ®Google Scholar
• Shimada K, Hayano M, Pagano NC, et al. Cell-line selectivity improves the predictive power of pharmacogenomic analyses and helps identify NADPH as biomarker for ferroptosis sensitivity. Cell Chem Biol. 2016;23(2):225–235.
   PubMed Web of Science ®Google Scholar
• Kim H, Lee JH, Park JW. Down-regulation of IDH2 sensitizes cancer cells to erastin-induced ferroptosis. Biochem Biophys Res Commun. 2020;525(2):366–371.
   PubMed Web of Science ®Google Scholar
• Wang TX, Liang JY, Zhang C, et al. The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis. Cell Death Dis. 2019;10(10):755.
   PubMed Web of Science ®Google Scholar
• Ding CC, Rose J, Sun T, et al. MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis. Nat Metab. 2020;2(3):270–277.
   PubMedGoogle Scholar
• Xie Y, Zhu S, Song X, et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep. 2017;20(7):1692–1704.
   PubMed Web of Science ®Google Scholar
• Yang WH, Ding CC, Sun T, et al. The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma. Cell Rep. 2019;28(10):2501–2508 e4.
   PubMed Web of Science ®Google Scholar
• Yang WH, Huang Z, Wu J, et al. A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer. Mol Cancer Res. 2020;18(1):79–90.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Yan B, Ai Y, Sun Q, et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell. 2021;81(2):355–369.e10.
   PubMed Web of Science ®Google Scholar
• Zou Y, Li H, Graham ET, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16(3):302–309.
   PubMed Web of Science ®Google Scholar
• Perez MA, Magtanong L, Dixon SJ, et al. Dietary lipids induce ferroptosis in caenorhabditiselegans and human cancer cells. Dev Cell. 2020;54(4):447–454.e4.
   PubMed Web of Science ®Google Scholar
• Lee JY, Nam M, Son HY, et al. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci U S A. 2020;117(51):32433–32442.
   PubMed Web of Science ®Google Scholar
• Ballatori N, Krance SM, Notenboom S, et al. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009;390(3):191–214.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1–2):1–12.
   PubMed Web of Science ®Google Scholar
• Liu X, Olszewski K, Zhang Y, et al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol. 2020;22(4):476–486.
   PubMedGoogle Scholar
• Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599–620.
   PubMed Web of Science ®Google Scholar
• Seco-Cervera M, González-Cabo P, Pallardó FV, et al. Thioredoxin and glutaredoxin systems as potential targets for the development of new treatments in Friedreich’s ataxia. Antioxidants (Basel). 2020;9(12):1257.
   Google Scholar
• Ingold I, Berndt C, Schmitt S, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell. 2018;172(3):409–422.e21.
   PubMed Web of Science ®Google Scholar
• Llabani E, Hicklin RW, Lee HY, et al. Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis. Nat Chem. 2019;11(6):521–532.
   PubMed Web of Science ®Google Scholar
• Soula M, Weber RA, Zilka O, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16(12):1351–1360.
   PubMed Web of Science ®Google Scholar
• Shimada K, Skouta R, Kaplan A, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol. 2016;12(7):497–503.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30(6):478–490.
   PubMed Web of Science ®Google Scholar
• Dai C, Chen X, Li J, et al. Transcription factors in ferroptotic cell death. Cancer Gene Ther. 2020;27(9):645–656.
   PubMed Web of Science ®Google Scholar
• Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81–90.
   PubMed Web of Science ®Google Scholar
• Tadokoro T, Ikeda M, Ide T, et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight. 2020;5(9):e132747.
   PubMed Web of Science ®Google Scholar
• Lim JKM, Delaidelli A, Minaker SW, et al. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance. Proc Natl Acad Sci U S A. 2019;116(19):9433–9442.
   PubMed Web of Science ®Google Scholar
• Ogiwara H, Takahashi K, Sasaki M, et al. Targeting the vulnerability of glutathione metabolism in ARID1A-deficient cancers. Cancer Cell. 2019;35(2):177–190.e8.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang L, Zhang X, et al. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53. EMBO Rep. 2019;20(7):e47563.
   PubMed Web of Science ®Google Scholar
• Kang R, Kroemer G, Tang D. The tumor suppressor protein p53 and the ferroptosis network. Free Radic Biol Med. 2019;133:162–168.
   PubMed Web of Science ®Google Scholar
• Tarangelo A, Magtanong L, Bieging-Rolett KT, et al. p53 suppresses metabolic Stress-Induced ferroptosis in cancer cells. Cell Rep. 2018;22(3):569–575.
   PubMed Web of Science ®Google Scholar
• Jiang L, Hickman JH, Wang SJ, et al. Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses. Cell Cycle. 2015;14(18):2881–2885.
   PubMed Web of Science ®Google Scholar
• Latunde-Dada GO. Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta Gen Subj. 2017;1861(8):1893–1900.
   PubMed Web of Science ®Google Scholar
• Zhang W, Gai C, Ding D, et al. Targeted p53 on small-molecules- induced ferroptosis in cancers. Front Oncol. 2018;8:507.
   PubMed Web of Science ®Google Scholar
• Wilson DF. Oxidative phosphorylation: regulation and role in cellular and tissue metabolism. J Physiol. 2017;595(23):7023–7038.
   PubMed Web of Science ®Google Scholar
• Galaris D, Barbouti A, Pantopoulos K. Iron homeostasis and oxidative stress: an intimate relationship. Biochim Biophys Acta Mol Cell Res. 2019;1866(12):118535.
   PubMed Web of Science ®Google Scholar
• Galadari S, Rahman A, Pallichankandy S, et al. Reactive oxygen species and cancer paradox: to promote or to suppress? Free radic. Free Radic Biol Med. 2017;104:144–164.
   PubMed Web of Science ®Google Scholar
• Doll S, Conrad M. Iron and ferroptosis: a still ill-defined liaison. IUBMB Life. 2017;69(6):423–434.
   PubMed Web of Science ®Google Scholar
• Maiorino M, Conrad M, Ursini F. GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid Redox Signal. 2018;29(1):61–74.
   PubMed Web of Science ®Google Scholar
• Haeggstrom JZ, Funk CD. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev. 2011;111(10):5866–5898.
   PubMed Web of Science ®Google Scholar
• Yang WS, Kim KJ, Gaschler MM, et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113(34):E4966–4975.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Naguro I, Ichijo H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochim Biophys Acta Gen Subj. 2019;1863(9):1398–1409.
   PubMed Web of Science ®Google Scholar
• Yi J, Zhu J, Wu J, et al. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A. 2020;117(49):31189–31197.
   PubMed Web of Science ®Google Scholar
• Zou Y, Henry WS, Ricq EL, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585(7826):603–608.
   PubMed Web of Science ®Google Scholar
• Lin Z, Liu J, Kang R, et al. Lipid metabolism in ferroptosis. Adv Biol (Weinh). 2021;5(8):e2100396.
   PubMedGoogle Scholar
• Ye Z, Liu W, Zhuo Q, et al. Ferroptosis: final destination for cancer? Cell Prolif. 2020;53(3):e12761.
   PubMed Web of Science ®Google Scholar
• Basuli D, Tesfay L, Deng Z, et al. Iron addiction: a novel therapeutic target in ovarian cancer. Oncogene. 2017;36(29):4089–4099.
   PubMed Web of Science ®Google Scholar
• Chitambar CR, Al-Gizawiy MM, Alhajala HS, et al. Gallium maltolate disrupts tumor iron metabolism and retards the growth of glioblastoma by inhibiting mitochondrial function and ribonucleotide reductase. Mol Cancer Ther. 2018;17(6):1240–1250.
   PubMedGoogle Scholar
• Naujokat C, Steinhart R. Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol. 2012;2012:950658.
   PubMedGoogle Scholar
• Yao X, Li W, Fang D, et al. Emerging roles of energy metabolism in ferroptosis regulation of tumor cells. Adv Sci (Weinh). 2021;8(22):e2100997.
   PubMedGoogle Scholar
• Payen VL, Mina E, Van Hée VF, et al. Monocarboxylate transporters in cancer. Mol Metab. 2020;33:48–66.
   PubMed Web of Science ®Google Scholar
• Zhu J, Xiong Y, Zhang Y, et al. The molecular mechanisms of regulating oxidative stress-induced ferroptosis and therapeutic strategy in tumors. Oxid Med Cell Longev. 2020;2020:8810785.
   PubMedGoogle Scholar
• Guo X, Liu F, Deng J, et al. Electron-accepting micelles deplete reduced nicotinamide adenine dinucleotide phosphate and impair two antioxidant cascades for ferroptosis-induced tumor eradication. ACS Nano. 2020;14(11):14715–14730.
   PubMed Web of Science ®Google Scholar
• Koike N, Kota R, Naito Y, et al. 2-Nitroimidazoles induce mitochondrial stress and ferroptosis in glioma stem cells residing in a hypoxic niche. Commun Biol. 2020;3(1):450.
   PubMedGoogle Scholar
• Qiu B, Simon MC. Oncogenes strike a balance between cellular growth and homeostasis. Semin Cell Dev Biol. 2015;43:3–10.
   PubMedGoogle Scholar
• Zhao Y, Hu X, Liu Y, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16(1):79.
   PubMedGoogle Scholar
• Villalobos C, Sobradillo D, n-MM H, et al. Calcium remodeling in colorectal cancer. Biochim Biophys Acta. 2017;1864(6):843–849.
   PubMed Web of Science ®Google Scholar
• Leontieva OV, Blagosklonny MV. Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression. Aging (Albany NY). 2011;3(11):1078–1091.
   PubMedGoogle Scholar
• Shibuya N, Inoue K, Tanaka G, et al. Augmented pentose phosphate pathway plays critical roles in colorectal carcinomas. Oncology. 2015;88(5):309–319.
   PubMed Web of Science ®Google Scholar
• Liu G, Kuang S, Cao R, et al. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway. FASEB J. 2019;33(9):10089–10103.
   PubMed Web of Science ®Google Scholar
• Clemente SM, Martínez-Costa OH, Monsalve M, et al. Targeting lipid peroxidation for cancer treatment. Molecules. 2020;25(21):5144.
   PubMed Web of Science ®Google Scholar
• Lyu Q, Tou F, Su H, et al. The natural product peiminine represses colorectal carcinoma tumor growth by inducing autophagic cell death. Biochem Biophys Res Commun. 2015;462(1):38–45.
   PubMedGoogle Scholar
• Sullivan LB, Gui DY, Heiden MG. Altered metabolite levels in cancer: implications for tumour biology and cancer therapy. Nat Rev Cancer. 2016;16(11):680–693.
   PubMed Web of Science ®Google Scholar
• Guo H, Ji F, Liu B, et al. Peiminine ameliorates bleomycin-induced acute lung injury in rats. Molecular Medicine Reports. 2013;7(4):1103–1110.
   PubMedGoogle Scholar
• Deberardinis RJ, Lum JJ, Hatzivassiliou G, et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11–20.
   PubMed Web of Science ®Google Scholar
• Daye D, Wellen KE. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis. Semin Cell Dev Biol. 2012;23(4):362–369.
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314.
   PubMed Web of Science ®Google Scholar
• Janakiram NB, Mohammed A, Brewer M, et al. Raloxifene and anti-estrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem like cells. Cancer Prev Res. 2014;7(3):300–309.
   PubMedGoogle Scholar
• Liu D, Jiang XY, Zhou LS, et al. Effects of probiotics on intestinal mucosa barrier in patients with colorectal cancer after operation: meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95(15):e3342.
   PubMed Web of Science ®Google Scholar
• Bai T, Wang S, Zhao Y, et al. Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2017;491(4):919–925.
   PubMed Web of Science ®Google Scholar